Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models

Cancer Letters(2024)10.1016/j.canlet.2024.217404Source: DataRank Database

A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models is a research paper published in Cancer Letters (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

cellosaurus uniprot pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.85)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Amanda M. Schalk,Kenneth Hofkens,Evelien Peeters ORCID,Sara T’Sas ORCID,Katrien Vandemeulebroecke ORCID

Live enrichment

PubMed:39709177 PMC:PMC12177098 OpenAlex:https://openalex.org/W4405589446

NCI NIH HHS

Grant: R43 CA243759

NIH HHS

Grant: S10 OD027016

NCI NIH HHS

Grant: R41 CA228622

BLRD VA

Grant: I01 BX001919

NCI NIH HHS

Grant: R43 CA232798

BLRD VA

Grant: I01 BX004589

NCI NIH HHS

Grant: R44 CA228622

FWCI

2.85

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.canlet.2024.217404

publisherhttps://doi.org/10.1016/j.canlet.2024.217404

publisherhttps://api.elsevier.com/content/article/PII:S0304383524007997?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383524007997?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39709177

Fields of Study

Acute Lymphoblastic Leukemia researchVirus-based gene therapy researchCytomegalovirus and herpesvirus researchAnimalsAsparaginaseHumansXenograft Model Antitumor AssaysAntineoplastic AgentsCell Line, TumorGuinea PigsMelanomaPrecursor Cell Lymphoblastic Leukemia-LymphomaLiver NeoplasmsGlutaminaseMiceFemaleAspartate-Ammonia Ligase

MeSH Terms

AnimalsAntineoplastic AgentsAsparaginaseAspartate-Ammonia LigaseFemaleGlutaminaseGuinea PigsHumansLiver NeoplasmsMelanomaXenograft Model Antitumor AssaysCell Line, TumorMicePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Keywords

Cancer researchLeukemiaSolid tumorAsparaginaseCancerGlutaminaseMedicineChemistryBiologyImmunologyLymphoblastic LeukemiaBiochemistryInternal medicineGlutamineMelanomaLiver cancerAsparagine synthetaseAcute lymphoblastic leukemia(Max 7)Asns(low) Solid Tumors

Sustainable Development Goals

SDG 0: Zero hunger

A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models

FAIR Checklist

Authors (14)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)